APA (7th ed.) Citation

S, S., SH, K., S, E., MR, T., S, N., MH, P., . . . S, K. (2025). Boswellic acids as an adjunct therapy in Parkinson's disease: A double-blind clinical trial investigating on its effects on motor symptoms and inflammatory markers. Inflammopharmacology, 33(11), 6791. https://doi.org/10.1007/s10787-025-01950-4

Chicago Style (17th ed.) Citation

S, Shateri, et al. "Boswellic Acids as an Adjunct Therapy in Parkinson's Disease: A Double-blind Clinical Trial Investigating on Its Effects on Motor Symptoms and Inflammatory Markers." Inflammopharmacology 33, no. 11 (2025): 6791. https://doi.org/10.1007/s10787-025-01950-4.

MLA (9th ed.) Citation

S, Shateri, et al. "Boswellic Acids as an Adjunct Therapy in Parkinson's Disease: A Double-blind Clinical Trial Investigating on Its Effects on Motor Symptoms and Inflammatory Markers." Inflammopharmacology, vol. 33, no. 11, 2025, p. 6791, https://doi.org/10.1007/s10787-025-01950-4.